Citigroup’s GeoVax Labs GOVX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$292 Buy
+230
New +$350 ﹤0.01% 5475
2025
Q4
Sell
-388
Closed -$4.59K 6206
2025
Q3
$4.59K Buy
388
+224
+137% +$3.92K ﹤0.01% 5254
2025
Q2
$3.55K Buy
+164
New +$4.09K ﹤0.01% 5319
2025
Q1
Sell
-201
Closed -$12.4K 5728
2024
Q4
$12.4K Sell
201
-263
-57% -$15.2K ﹤0.01% 5345
2024
Q3
$28K Buy
+464
New +$39K ﹤0.01% 5130
2022
Q2
Sell
-9
Closed -$4K 6391
2022
Q1
$4K Buy
+9
New +$7.16K ﹤0.01% 5888

Other funds holding GOVX

Citigroup's GOVX Position: Q2 2026 in Review

Citigroup opened a new position in GeoVax Labs (GOVX) in Q2 2026: 230 shares worth $292. The stake represents ﹤0.01% of the portfolio and ranks #5475 among its holdings. This is a return to the name: Citigroup previously reported a position in GOVX as recently as Q3 2025.

Citigroup first reported a position in GOVX in Q1 2022 and has held it in 6 quarters since. The position peaked at $28K in Q3 2024. 11 funds tracked by Wall St. Rank hold GOVX as of Q2 2026.

  • Citigroup held 230 shares of GeoVax Labs worth $292 as of Q2 2026.
  • GeoVax Labs was a new Citigroup position in Q2 2026.
  • GeoVax Labs made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5475 holding.
  • Citigroup first reported a position in GeoVax Labs in Q1 2022 and has held it in 6 quarters since.
  • Citigroup's GeoVax Labs position peaked at $28K in Q3 2024.
  • 11 funds tracked by Wall St. Rank held GeoVax Labs as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.